Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Current directions in autoimmunity

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000060499PMID 11791460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporine induces cancer progression by a cell-autonomous mechanism

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

  1999cited by this paper
• Etanercept Therapy in Rheumatoid Arthritis

  1999cited by this paper
• A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

  1999cited by this paper
• Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

  1999cited by this paper
• Anti‐IL‐12 and anti‐TNF antibodies synergistically suppress the progression of murine collagen‐induced arthritis

  1999cited by this paper
• An anti‐inflammatory role for interleukin‐11 in established murine collagen‐induced arthritis

  1998cited by this paper
• Blockade of IL‐12 during the induction of collagen‐induced arthritis (CIA) markedly attenuates the severity of the arthritis

  1998cited by this paper
• Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen‐induced arthritis

  1997cited by this paper
• Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.

  1997cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Suppression of collagen-induced arthritis by continuous administration of IL-4.

  1997cited by this paper
• Decrease in cell adhesion molecules by treatment with anti-tumor necrosis factor alpha monoclonal antibody.

  1997cited by this paper
• Effect of IL-10 on collagen-induced arthritis in mice

  1996cited by this paper
• Interleukin‐10 Suppresses the Development of Collagen Type II‐Induced Arthritis and Ameliorates Sustained Arthritis in Rats

  1996cited by this paper
• Cyclosporine, FK-506, rapamycin, and other immunomodulators.

  1996cited by this paper
• Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.

  1996cited by this paper
• Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.

  1996cited by this paper
• Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis

  1996cited by this paper
• Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.

  1995cited by this paper
• Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7.

  1995cited by this paper
• Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis.

  1995cited by this paper
• The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

  1995cited by this paper
• Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.

  1995cited by this paper
• Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

  1994cited by this paper
• Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

  1994cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

  1994cited by this paper
• Receptor-mediated label-transfer assay (RELAY): a novel method for the detection of plasma tumor necrosis factor at attomolar concentrations.

  1994cited by this paper
• The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice

  1994cited by this paper
• Interleukin-1, tumor necrosis factor and their specific inhibitors.

  1994cited by this paper
• Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia

  1994cited by this paper
• Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.

  1993cited by this paper
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

  1993cited by this paper
• Circulating adhesion molecules in disease.

  1993cited by this paper
• FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

  1992cited by this paper
• Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor.

  1992cited by this paper
• E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro.

  1992cited by this paper
• Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice.

  1992cited by this paper
• Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever

  1992cited by this paper
• Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

  1992cited by this paper
• Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors

  1991cited by this paper
• Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor‐α

  1991cited by this paper
• Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.

  1991cited by this paper
• Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group.

  1990cited by this paper
• Structure of tumour necrosis factor

  1989cited by this paper
• A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

  1989cited by this paper
• Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms.

  1989cited by this paper
• Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected].

  1989cited by this paper
• Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

  1989cited by this paper
• A human inhibitor of tumor necrosis factor alpha

  1988cited by this paper
• The progression of the inflammation in established collagen‐induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities

  1988cited by this paper
• Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

  1987cited by this paper
• CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

  1987cited by this paper
• Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

  1985cited by this paper
• Human tumor necrosis factor. Production, purification, and characterization.

  1985cited by this paper
• Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor

  1985cited by this paper
• Molecular cloning of the complementary DNA for human tumor necrosis factor.

  1985cited by this paper
• Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

  1984cited by this paper
• Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

  1984cited by this paper
• Collagen arthritis as a relevant model for rheumatoid arthritis.

  1982cited by this paper
• Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG

  1979cited by this paper

• A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis

  2016cites this paper
• Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects.

  2014cites this paper
• 34 – Biologic Markers

  2013cites this paper
• Adiponectin induces CCL20 expression synergistically with IL-6 and TNF-α in THP-1 macrophages.

  2012cites this paper
• Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model

  2012cites this paper
• IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system

  2009cites this paper
• Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis.

  2009cites this paper
• Intramolecular interactions of MARCKS and its relationship to tumor necrosis factor -alpha and rheumatoid arthritis

  2008cites this paper
• Immune Modulation and Tolerance Induction by RelB-Silenced Dendritic Cells through RNA Interference1

  2007cites this paper
• Interleukin‐10 in murine metal‐induced systemic autoimmunity

  2005cites this paper
• PHARMACOKINETIC MODELING OF DYNAMIC MR IMAGING IN THE KNEE OF CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS

  2005cites this paper
• RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family.

  2004cites this paper
• Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate.

  2003cites this paper
• Verfahren zur prävention oder behandlung von entzündlichen erkrankungen oder autoimmunkrankheiten durch verabreichung von integrin-alphav-beta3-antagonisten

  2002cites this paper
• Immunological Tolerance: Therapeutic Induction

  2001cites this paper